Another year at the J.P. Morgan Healthcare Conference is in the books. | While major payers skipped out on this year’s event, ...

In the wake of the 2024 U.S. elections, stakeholders in the life sciences and health care industry are intensely focused on the policy ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

Healthcare leaders shared insights on various topics, including industry challenges, a new administration and growing their ...

Health care executives continue to reimagine and reshape their organizations. Their ideas were developing in real time during ...

This year's JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in ...

Read here for an analysis of Koninklijke Philips' performance and 2025 outlook, highlighting challenges and revised sales ...

A tide change is rippling across healthcare. As industry leaders converged on San Francisco for the 2025 JP Morgan Healthcare conference, they echoed optimism about a renewed stability in healthcare, ...

The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public companies.

Thousands of health-care executives descended on JPMorgan's annual health-care conference in San Francisco this week. The conference took place a month after UnitedHealthcare CEO Brian Thompson ...